"QUICK START" SXEMASI BO‘YICHA FOLATLI KOK QO‘LLASH ORQALI HOMILADORLIKNING ERTA MUDDATLARIDA TO‘XTATILISHIDAN SO‘NG ABORTDAN KEYINGI REABILITATSIYANI OPTIMALLASHTIRISH: GORMONAL VA REPRODUKTIV SAMARADORLIK
##article.subject##:
homiladorlikni erta tugatish, abortdan keyingi parvarish, gormonal muvozanat, moslashish, jarrohlik va farmakologik usullar, gormonal tuzatish, foliy kislotasi o'z ichiga olgan kontratseptivlar##article.abstract##
Homiladorlikning erta tugashi ayolning umumiy salomatligi va reproduktiv salohiyatiga ta'sir qiluvchi muhim omil hisoblanadi. O‘zbekistonda abortlar soni kamayganiga qaramay, bepushtlik va endokrin kasalliklar kabi asoratlar dolzarb muammo bo‘lib qolmoqda. Ushbu tadqiqot abortdan keyingi parvarishning optimal usullarini aniqlash uchun erta abortdan keyin ayollarning gormonal holati va moslashuvini o'rganishga qaratilgan. Tadqiqotda reproduktiv yoshdagi 100 nafar ayol ishtirok etdi; holatlar tarixini retrospektiv tahlil qilish, gormonal profilni baholash, klinik va biokimyoviy tadqiqotlar va ultratovush tekshiruvi o'tkazildi. Aniqlanishicha, homiladorlikning erta tugashi gormonal muvozanatni buzadi va moslashish davrini uzaytiradi, tug'ilish va keyingi homiladorlik natijalariga ta'sir qiladi. Farmakologik usullar jarrohlik bilan solishtirganda kamroq buzilishlar bilan bog'liq edi va gormonal tuzatish, ayniqsa folat o'z ichiga olgan kontratseptivlar bilan birgalikda, tezroq tiklanishga yordam berdi. Natijalar abortdan keyingi reabilitatsiya va kontseptsiyadan oldin tayyorgarlik ko'rish uchun individual, gormonal yo'naltirilgan yondashuv zarurligini ta'kidlaydi.
Библиографические ссылки
Алексюк МЮ, et al. Регуляторно-адаптационный потенциал после медикаментозного аборта. Фунд Мед Биол. 2017;2:37–39.
Алехина АГ. Влияние искусственного прерывания беременности на репродуктивные возможности женщин. Журнал акушерства и женских болезней. 2019;68(4):45–52.
Байкулова ТЮ, Петров ЮА. Беременность у первобеременных с абортивным анамнезом. Валеология. 2016;1:85–95.
Госкомстат РУз. О снижении числа абортов в Узбекистане. Ташкент: 2022. Доступно: https://stat.uz/ru/press-tsentr/novosti-goskomstata/22624-o-zbekistonda-homiladorlikni-to-xtatish-abort-lar-soni-kamaydi-2
Министерство здравоохранения РУз. Национальная стратегия репродуктивного здоровья. Ташкент: 2020.
American College of Obstetricians and Gynecologists. Access to postabortion contraception. Committee Opinion No. 833. Obstet Gynecol. 2021;138(2):e91–e95.
American College of Obstetricians and Gynecologists. Early pregnancy loss. Practice Bulletin No. 200. Obstet Gynecol. 2018;132(5):e197–e207.
Bayer HealthCare. SAFYRAL (drospirenone/ethinyl estradiol/levomefolate calcium) prescribing information. 2022.
Berer M, Henshaw SK. Global review of abortion incidence and mortality. Popul Rep. 2001;30(1):1–44.
Beyond safety: the 2022 WHO abortion guidelines. BMJ Glob Health. 2022;7(6):e009557. doi:10.1136/bmjgh-2022-009557.
Bridwell RE, et al. Post-abortion Complications: A Narrative Review for Clinicians. Cureus. 2022;14(10):e30323. doi:10.7759/cureus.30323.
National Institute for Health and Care Excellence. Abortion Care. NICE guideline NG140. London: NICE; 2019.
National Institutes of Health. Medical abortion. Office of Women's Health. 2018.
Pritchard J, McIntyre S. Hormonal stress response in reproductive health post-abortion. J Reprod Med. 2015;63(2):125–131.
Royal College of Obstetricians and Gynaecologists. Best Practice in Post-Abortion Contraception. London: RCOG; 2022.
Van Hylckama Vlieg A, et al. The venous thrombotic risk of oral contraceptives. BMJ. 2009;339:b2921. doi:10.1136/bmj.b2921.
Winikoff B, Dzuba IG. Extending outpatient medical abortion services through 70 days. Obstet Gynecol. 2012;120(5):1070–1076.
World Health Organization. Abortion care guideline. Geneva: WHO; 2022.
World Health Organization. Safe abortion: technical and policy guidance. Geneva: WHO; 2012.
World Health Organization. Unsafe abortion: global and regional estimates. Geneva: WHO; 2018.
